Limiting access to letrozole--is it justified?
Tulandi T, DeCherney AH
Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada. togas.tulandi@mcgill.ca
Letrozole is an effective drug for ovulation induction and superovulation. Limiting its access is a disservice to our infertile patients and to the advancement in ovulation-related research.
Published 8 October 2007 in Fertil Steril, 88(4): 779-80.
Full-text of this article is available online (may require subscription).
© 2004-2008 Infertility Research Today. All Rights Reserved.
|